Nancy Lurker - 20 Jun 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
CEO, Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
20 Jun 2023
Net transactions value
$0
Form type
4
Filing time
22 Jun 2023, 09:14:20 UTC
Previous filing
15 May 2023
Next filing
12 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +225,400 $0.000000 225,400 20 Jun 2023 Common Stock 225,400 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest in three ratable annual installments beginning January 6, 2024.